Apollo-backed Covis to buy AMAG Pharmaceuticals

Covis, which is backed by Apollo Global Management, has agreed to acquire AMAG Pharmaceuticals for $13.75 per share in cash.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this